APO RESEARCH · REPORT
Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine
Selected research
Industry Research
Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Research Report 2026
Market perspective
The global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine include Johnson & Johnson, Merck & Co., Inc., Pfizer Inc., GlaxoSmithKline Plc, Serum Institute of India, Sanofi Pasteur, Emergent Biosolutions and CSL Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (doses), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/doses) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Company
Johnson & Johnson
Merck & Co., Inc.
Pfizer Inc.
GlaxoSmithKline Plc
Serum Institute of India
Sanofi Pasteur
Emergent Biosolutions
CSL Limited
Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Segment by Type
Pediatric Hepatitis B (CHO) Vaccine
Adult Hepatitis B (CHO) Vaccine
Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Segment by Application
Hospitals
Clinics
Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Pediatric Hepatitis B (CHO) Vaccine
- Adult Hepatitis B (CHO) Vaccine
Applications
- Hospitals
- Clinics
Companies covered
- Johnson & Johnson
- Merck & Co., Inc.
- Pfizer Inc.
- GlaxoSmithKline Plc
- Serum Institute of India
- Sanofi Pasteur
- Emergent Biosolutions
- CSL Limited
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size (2021-2032)
- 2.2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (2021-2032)
- 2.2.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Average Price (2021-2032)
- 2.3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Pediatric Hepatitis B (CHO) Vaccine
- 2.3.3 Adult Hepatitis B (CHO) Vaccine
- 2.4 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Clinics
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (doses) of Manufacturers (2021-2026)
- 3.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue of Manufacturers (2021-2026)
- 3.4 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Average Price by Manufacturers (2021-2026)
- 3.5 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine, Product Type & Application
- 3.8 Global Manufacturers of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine, Established Date
- 3.9 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Johnson & Johnson
- 4.1.1 Johnson & Johnson Company Information
- 4.1.2 Johnson & Johnson Business Overview
- 4.1.3 Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio
- 4.1.5 Johnson & Johnson Recent Developments
- 4.2 Merck & Co., Inc.
- 4.2.1 Merck & Co., Inc. Company Information
- 4.2.2 Merck & Co., Inc. Business Overview
- 4.2.3 Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio
- 4.2.5 Merck & Co., Inc. Recent Developments
- 4.3 Pfizer Inc.
- 4.3.1 Pfizer Inc. Company Information
- 4.3.2 Pfizer Inc. Business Overview
- 4.3.3 Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio
- 4.3.5 Pfizer Inc. Recent Developments
- 4.4 GlaxoSmithKline Plc
- 4.4.1 GlaxoSmithKline Plc Company Information
- 4.4.2 GlaxoSmithKline Plc Business Overview
- 4.4.3 GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio
- 4.4.5 GlaxoSmithKline Plc Recent Developments
- 4.5 Serum Institute of India
- 4.5.1 Serum Institute of India Company Information
- 4.5.2 Serum Institute of India Business Overview
- 4.5.3 Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio
- 4.5.5 Serum Institute of India Recent Developments
- 4.6 Sanofi Pasteur
- 4.6.1 Sanofi Pasteur Company Information
- 4.6.2 Sanofi Pasteur Business Overview
- 4.6.3 Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio
- 4.6.5 Sanofi Pasteur Recent Developments
- 4.7 Emergent Biosolutions
- 4.7.1 Emergent Biosolutions Company Information
- 4.7.2 Emergent Biosolutions Business Overview
- 4.7.3 Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio
- 4.7.5 Emergent Biosolutions Recent Developments
- 4.8 CSL Limited
- 4.8.1 CSL Limited Company Information
- 4.8.2 CSL Limited Business Overview
- 4.8.3 CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Portfolio
- 4.8.5 CSL Limited Recent Developments
5 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Scenario by Region
- 5.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region: 2021-2032
- 5.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region: 2021-2026
- 5.2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region: 2027-2032
- 5.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region: 2021-2032
- 5.3.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region: 2021-2026
- 5.3.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region: 2027-2032
- 5.4 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Facts & Figures by Country
- 5.4.1 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2021-2032)
- 5.4.3 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Facts & Figures by Country
- 5.5.1 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2021-2032)
- 5.5.3 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Facts & Figures by Country
- 5.7.1 South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2021-2032)
- 5.7.3 South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2021-2032)
- 6.1.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2021-2032) & (doses)
- 6.1.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Type (2021-2032)
- 6.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type (2021-2032)
- 6.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Type (2021-2032)
- 6.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2021-2032)
- 7.1.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2021-2032) & (doses)
- 7.1.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Application (2021-2032)
- 7.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2021-2032)
- 7.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Application (2021-2032)
- 7.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Value Chain Analysis
- 8.1.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Mode & Process
- 8.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Distributors
- 8.2.3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Customers
9 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Analyzing Market Dynamics
- 9.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Trends
- 9.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Drivers
- 9.3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Opportunities and Challenges
- 9.4 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst